NATHAN FOWLER to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications NATHAN FOWLER has written about TOR Serine-Threonine Kinases.
Connection Strength
0.083
-
Developing novel strategies to target B-cell malignancies. Am Soc Clin Oncol Educ Book. 2013; 366-72.
Score: 0.066
-
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma. Clin Cancer Res. 2013 Dec 15; 19(24):6882-90.
Score: 0.017